ExpreS2ion Biotech Holding AB (publ) Operating Income

ExpreS2ion Biotech Holding AB (publ) (EXPRS2.ST) currently reports a operating income of $-64M as of June 2026. That compares with $-57M in the prior-year period — down 12.4% year over year. Use the charts on this page to explore ExpreS2ion Biotech Holding AB (publ)'s operating income history and peer comparisons.

ExpreS2ion Biotech Holding AB (publ)'s operating income decreased from $-57M to $-64M — a 12.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ExpreS2ion Biotech Holding AB (publ) reported $-64M in operating income as of June 2026. That compares with $-57M in the prior-year period — down 12.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-64M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ExpreS2ion Biotech Holding AB (publ), and consider following EXPRS2.ST for alerts when major investors trade the stock.

ExpreS2ion Biotech Holding AB (publ) is classified in the Healthcare sector. On operating income, it currently shows $-64M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing EXPRS2.ST with unrelated industries.